Search results
Moderna’s COVID, flu combination vaccine shows stronger immune response, company announces
KIRO 7 Seattle-Tacoma· 14 hours agoModerna is working on a single vaccine that it says will protect people against both COVID-19 and...
Moderna’s combo COVID and flu vaccine works better than stand-alone shots on the market, study finds
Market Watch· 19 hours agoexperimental combination COVID and flu vaccine triggered better immune responses than stand-alone...
2-in-1 shot for flu and COVID shows promise in advanced trial
Live Science via Yahoo News· 8 hours agoOne major benefit of a combination vaccine would be that it would streamline that vaccination...
With 100M birds dead, poultry industry could serve as example as dairy farmers confront bird flu
ABC News· 42 minutes agoAs the U.S. dairy industry confronts a bird flu outbreak, with cases reported at dozens of farms and...
FDA gives nod to RSV vaccine for people in their 50s
Medical Xpress· 10 hours agoDrugmaker GSK's Arexvy vaccine, as well as vaccines from Pfizer and Moderna, are already approved for use in adults 60 and older, since age brings higher...
Moderna to present combo COVID-flu vaccine to regulators after trial
Scripps News via AOL· 14 hours agoModerna compared the immune response between those who were given mRNA-1083 versus those who were...
A Combined Flu and COVID-19 Shot May Be Coming
Time via AOL· 11 hours agoHD for those 65 and older). In the younger group, the combo vaccine generated about 20% to 40% higher levels of antibodies to the influenza strains, and...
FDA Advisors Give a Hearty Thumbs Up to a COVID Vaccine Based on the JN.1 Strain
MedPage Today· 6 days agoAn FDA advisory committee voted unanimously, 16-0, Wednesday to recommend that the COVID-19 vaccines...
New COVID-19 vaccine for fall should target JN.1 lineage, not variant, FDA panel
USA TODAY via Yahoo News· 5 days agoCurrent vaccines built to fight XBB.1.5 also don’t provide as much protection against JN.1 and...
COVID shots should target variants with JN.1 lineage in 2024-25 campaign, US FDA advisers say By...
Investing.com· 6 days agoCOVID shots should target variants with JN.1 lineage in 2024-25 campaign, US FDA advisers say